On March 7, Dongfulong issued an announcement on the “Double Improvement of Quality and Return” action plan. The company said that after 30 years of development, it has grown into a comprehensive pharmaceutical equipment service provider providing global pharmaceutical companies with overall pharmaceutical technology, core equipment, and system engineering solutions. With competitive advantages such as technological innovation, perfect sales network layout, leading brand influence and comprehensive solution services within the industry, the company is in a leading position in the domestic pharmaceutical equipment field, and has continuously narrowed the gap with leading international peers, gradually achieving domestic replacement while developing overseas markets.
东富龙：专业技术服务于生物医药，助力人类大健康事业发展
Dongfulong: Professional technology serves biomedicine to help the development of human health
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.